[[Founder's Fund]] | [[2010s]] | [[Elon Musk]] | [[Ben Rapoport]] | [[Max Hodak]] | [[Donglin Seo]] | [[Paul Merolla]] | [[Philip Sabes]] | [[Timothy Gardner]] | [[Vanessa Tolosa]] ## Company Overview and Strategic Position Neuralink Corporation is a neurotechnology company developing implantable brain-computer interfaces (BCIs) with the stated goal of helping people with paralysis and eventually achieving "symbiosis" between human intelligence and artificial intelligence. Founded in 2016 by **Elon Musk** and a team of scientists and engineers, the company represents one of the most ambitious attempts to directly interface human brains with computers. While still pre-revenue and in early clinical stages, Neuralink's work has profound implications for medicine, human enhancement, privacy, and the nature of human cognition itself. ## Founding and Key Personnel (2016-Present) ### Founding Team Neuralink was co-founded in 2016 by: - **Elon Musk** (CEO and primary funder) - **Max Hodak** (President until 2021) - **Ben Rapoport** (neurosurgeon) - **Dongjin "DJ" Seo** (electrical engineer, UC Berkeley) - **Paul Merolla** (chip designer, previously at IBM) - **Philip Sabes** (neuroscientist, UCSF) - **Timothy Gardner** (neuroscientist, Boston University) - **Vanessa Tolosa** (materials scientist, Lawrence Livermore National Laboratory) The team combined expertise in neuroscience, electrical engineering, robotics, and chip design—disciplines essential for creating implantable neural interfaces. ### Leadership Evolution and Departures **Max Hodak** (Co-founder, President): Departed in 2021 under unclear circumstances. His exit removed a key scientific and operational leader. Hodak later founded Science Corporation, a competing neurotechnology company, and made public statements questioning some of Neuralink's approaches and timeline claims. **Significant Scientific Departures**: Multiple co-founders and key scientists have left the company: - **Benjamin Rapoport** departed in 2018 - **Philip Sabes** left after several years - **Vanessa Tolosa** departed - Multiple other engineers and scientists have cycled through **Implications**: The high turnover among scientific leadership raises questions about internal culture, Musk's management style, and whether timelines and goals are scientifically realistic versus driven by Musk's typical aggressive deadline setting. **Current Leadership**: - **Elon Musk**: CEO and primary decision-maker - **Shivon Zilis**: Director of Operations and Special Projects (also executive at Musk's Neuralink and mother of two of Musk's children) - **DJ Seo**: Still with the company in technical leadership role - Various engineers and neuroscientists (specific roles often not publicly disclosed due to company opacity) ## Technology and Approach ### The Neuralink Device **Current Design (N1 Implant)**: - Coin-sized device (~23mm diameter) implanted flush with skull - Contains 1,024 electrodes across 64 ultra-thin threads (5 micrometers wide) - Threads inserted into brain tissue by custom surgical robot - Wireless data transmission and inductive charging - Intended to record neural activity and eventually stimulate neurons **Surgical Robot**: - Custom-built robot to insert flexible electrode threads with precision - Designed to avoid blood vessels using computer vision - Key innovation allowing insertion of far more electrodes than traditional methods - Robot represents substantial engineering achievement independent of the implant itself **Theoretical Advantages Over Existing BCIs**: - Higher electrode count than most existing systems (though not unprecedented) - Wireless operation (no percutaneous connectors) - Flexible threads potentially reduce tissue damage compared to rigid electrodes - Intended for long-term implantation ### Technical Context and Competition Neuralink is not operating in isolation. The brain-computer interface field includes: **Academic Research**: Decades of BCI research at institutions like Stanford, University of Pittsburgh, Brown University, and others have demonstrated control of cursors, robotic arms, and communication through thought. **Commercial Competitors**: - **Synchron**: Australian-American company with FDA approval for human trials (received before Neuralink), using less invasive endovascular approach through blood vessels - **Blackrock Neurotech**: Long-established company with Utah Array technology used in many research studies - **Paradromics**: Developing high-bandwidth neural interface - **Precision Neuroscience**: Founded by Neuralink co-founder Benjamin Rapoport, using surface-level electrode array avoiding penetration - **Kernel**: Bryan Johnson's company focused on non-invasive approaches **Geopolitical Context**: Neural technology development is occurring globally, with significant Chinese and European research programs. Brain-computer interfaces represent potential strategic technology for military applications, human enhancement, and AI integration. ## Stated Goals and Timeline Evolution ### Initial Vision (2016-2019) Musk initially described extraordinarily ambitious goals: - Treating neurological conditions (paralysis, blindness, deafness) - Enabling telepathic communication - Downloading/uploading thoughts and memories - Achieving AI-human symbiosis to prevent humans from becoming irrelevant as AI advances - "Wizard hat for the brain" to enhance cognition **2019 Public Presentation**: Neuralink showcased its technology publicly, demonstrating the surgical robot and thread technology. Musk claimed human trials would begin in 2020. ### Timeline Slippage **Reality of Timelines**: - **2020 human trials**: Did not occur - **2021 human trials**: Did not occur - **2022 human trials**: Did not occur (FDA rejected initial application) - **2023**: FDA approval finally granted in May - **January 2024**: First human implant performed - **August 2024**: Second human implant This pattern of dramatically optimistic timelines followed by delays mirrors Musk's approach across his companies (Tesla's Full Self-Driving promises, Mars colonization dates, etc.). **Implications**: The repeated timeline misses raise questions about whether Musk's public statements reflect realistic technical assessments or serve primarily to generate excitement, recruit talent, and attract funding. This tension between promotional vision and scientific reality runs throughout Neuralink's history. ## Animal Testing Controversies and Regulatory Issues ### Monkey Testing Allegations (2022) In February 2022, the **Physicians Committee for Responsible Medicine (PCRM)**, an animal rights advocacy group, filed a complaint with the USDA alleging Neuralink violated the Animal Welfare Act through experiments at University of California, Davis (2017-2020). **Specific Allegations**: - 23 monkeys died or were euthanized between 2017-2020 - Monkeys suffered from infections, hemorrhaging, paralysis, and seizures related to implants - Inadequate post-surgical care - Use of "BioGlue" product that caused severe inflammation when it leaked - Euthanasia of animals when experiments failed rather than providing treatment - Psychological suffering from inadequate enrichment **Neuralink's Response**: The company claimed: - Work complied with all regulations - Terminal procedures are standard in neuroscience research - Number of animals used was actually lower than typical - Deaths were related to learning curve of developing new technology - Significant efforts were made to minimize suffering **Independent Documentation**: Leaked photos and veterinary records appeared to support some allegations, showing monkeys with severe infections and brain damage. **Geopolitical and Ethical Implications**: This controversy highlights tensions between rapid technological development and animal welfare protections. The allegations suggest pressure to move quickly (characteristic of Musk's companies) may have compromised animal welfare. It raised questions about whether Neuralink's internal culture prioritizes speed over careful scientific and ethical practice. ### FDA Approval Process **Initial Rejection (2022)**: The FDA rejected Neuralink's application for human trials, citing concerns including: - Lithium battery safety (risk of overheating/fire in the brain) - Wires migrating to other brain areas - Safe removal of the device without damaging brain tissue - Overall risk-benefit analysis **Approval (May 2023)**: After additional testing and design modifications, FDA granted approval for human clinical trials under an Investigational Device Exemption (IDE). **Implications**: The initial rejection suggested FDA had concerns about Neuralink's approach despite Musk's public confidence. The regulatory process forced more rigorous safety evaluation than Neuralink's aggressive timeline preferred. ### Ongoing USDA Investigation In 2023, reports emerged that the **USDA Inspector General** was investigating Neuralink for potential violations of the Animal Welfare Act. The investigation reportedly focused on: - Whether experiments were conducted improperly - Whether the research team rushed experiments causing unnecessary animal deaths - Whether accurate records were maintained **Status**: As of early 2025, the investigation's outcome has not been publicly disclosed. ## Human Clinical Trials ### PRIME Study (First Human Trials) **First Patient - Noland Arbaugh (January 2024)**: Neuralink implanted its device in **Noland Arbaugh**, a 29-year-old man paralyzed from the shoulders down after a diving accident. Initial results appeared promising: - Arbaugh demonstrated ability to control computer cursor with thoughts - Played online chess and the video game Civilization VI - Browsed the internet and used social media - Neuralink released videos showing these capabilities **Thread Retraction Problem (March-April 2024)**: Approximately a month after implantation, many electrode threads retracted from Arbaugh's brain tissue, significantly reducing the number of functioning electrodes. Neuralink modified software algorithms to compensate but did not initially disclose the problem publicly. When reported by _The Wall Street Journal_ in May 2024, questions arose about: - Why thread retraction occurred - Whether Neuralink anticipated this possibility - The company's transparency about complications - Implications for future patients Neuralink considered removing the implant but ultimately decided against it as Arbaugh was still achieving some functionality and wasn't experiencing adverse effects. **Implications**: This complication in the very first human trial revealed potential technical challenges with the thread-based approach. The delayed public disclosure raised concerns about transparency characteristic of Musk's companies, which often control information tightly. **Second Patient (August 2024)**: Neuralink implanted a second patient, reportedly also a person with paralysis. Limited information has been publicly released. Neuralink claimed they modified implantation technique to reduce risk of thread retraction based on first patient's experience. ### Trial Design and Patient Selection **Eligibility**: Current trials focus on people with quadriplegia due to spinal cord injury or ALS (amyotrophic lateral sclerosis) at least one year post-injury with limited hand function. **Goals**: Initial trials aim to demonstrate safety and basic functionality—enabling patients to control digital devices through thought. **Size and Timeline**: The PRIME study received approval for up to 10 patients initially. As of early 2025, only two implants have been performed, suggesting slower progress than Musk's public statements about "scaling up" might imply. ## Major Controversies and Concerns ### Transparency and Scientific Publication **Limited Peer-Reviewed Research**: Unlike typical medical device development, Neuralink has published minimal peer-reviewed scientific research. Most information comes through: - Company blog posts and press releases - Musk's social media posts (X/Twitter) - Promotional livestream events - Selected media interviews **Implications**: This approach prioritizes publicity over scientific scrutiny. Peer review allows independent experts to evaluate methodology, interpret results, and assess claims before they reach the public. Neuralink's approach means: - Extraordinary claims are not independently verified - Potential risks or limitations may not be disclosed - The scientific community cannot build on or critique the work effectively - Public perception may be shaped by marketing rather than evidence This reflects broader patterns in Musk's companies (Tesla's self-driving claims, SpaceX's Mars timelines) where public promotion precedes scientific consensus. ### Data Privacy and Security Concerns **Unprecedented Access to Neural Data**: Brain-computer interfaces collect extraordinarily intimate data—the literal electrical patterns of human thought. This raises questions: **Data Ownership**: Who owns the neural data? The patient? Neuralink? Third parties who might purchase it? **Security**: Brain implants are hackable technology. Potential concerns include: - Unauthorized access to neural data revealing private thoughts, intentions, or medical information - Manipulation of brain stimulation to influence behavior, mood, or cognition - Ransomware attacks on brain implants - Weaponization by hostile actors **Regulatory Gap**: Current privacy laws (HIPAA, GDPR) don't adequately address neural data. Brain activity data could reveal: - Neurological and psychiatric conditions - Cognitive states (attention, stress, emotional states) - Potentially intentions or thoughts (though this remains scientifically distant) - Biometric identification more unique than fingerprints or retinal scans **Musk's Track Record on Privacy**: Given controversies at X/Twitter regarding data practices and Musk's positions on various privacy issues, concerns exist about how Neuralink would handle neural data, particularly as business pressures increase. **Geopolitical Implications**: Neural data security becomes a national security concern if adversaries could access, manipulate, or sabotage brain implants. Foreign intelligence agencies would have obvious interests in such capabilities. ### Military and Dual-Use Concerns **DARPA Connections**: Brain-computer interface research has substantial military funding through the Defense Advanced Research Projects Agency (DARPA). While Neuralink hasn't publicly disclosed military contracts, the technology has obvious defense applications: - Enhanced soldier cognitive performance - Direct brain control of weapons systems or drones - Telepathic communication between unit members - Treating traumatic brain injury and PTSD in veterans **Implications**: The line between medical device and military technology is blurred. International governance of neural interfaces as potential weapons or enhancement technologies remains undeveloped. ### Enhancement vs. Medical Device **Mission Creep**: While current trials focus on disability, Musk's stated goal is human enhancement—making healthy people "smarter" and enabling AI-human symbiosis. This raises profound questions: **Equity and Access**: If neural enhancement becomes possible: - Will it create a cognitive aristocracy? - Who will have access? (Likely the wealthy initially) - Could this increase inequality more dramatically than any previous technology? - Will people need enhancement to remain competitive in the job market? **Coercion**: If enhancement becomes normalized: - Will people feel compelled to get implants to compete? - Will employers require or pressure employees to get enhanced? - How do we protect autonomy when opting out means disadvantage? **Human Identity**: Enhancement raises existential questions: - What does it mean to be human if we're augmented by AI? - Where is the boundary between human thought and machine computation? - Could this create psychological or philosophical crises? **Regulation**: Current medical device regulations assume therapeutic purposes. Enhancement falls into regulatory gray areas, potentially allowing deployment before society addresses implications. ### Musk's Conflicts of Interest and Motivations **AI Concerns Driving BCI Development**: Musk has repeatedly stated he views artificial general intelligence (AGI) as an existential threat to humanity. He argues neural interfaces are humanity's only hope to remain relevant as AI surpasses human intelligence. **Conflicting Business Interests**: - Musk simultaneously develops AI (xAI, Grok, earlier involvement with OpenAI) - He promotes AI development while warning about AI dangers - Neuralink is positioned as solution to problem Musk's other companies may be creating **Implications**: Musk's AI narrative serves to: - Generate urgency and funding for Neuralink - Position himself as visionary addressing an existential threat - Potentially create markets for his own technologies The sincerity versus self-interest in Musk's AI warnings and neural interface advocacy remains debated. ### Workplace Culture Concerns **Reports of High-Pressure Environment**: Consistent with other Musk companies, reports describe: - Extremely long working hours - Aggressive deadlines disconnected from scientific/engineering realities - High turnover among staff - Musk's direct involvement overriding scientific judgment - Prioritization of publicity timelines over careful development **Implications**: This culture may increase risks of: - Rushed development compromising safety - Scientific corners being cut - Ethical oversights - Staff afraid to raise concerns This pattern across Musk's companies (Tesla Autopilot development controversies, SpaceX workplace issues) suggests organizational culture may prioritize Musk's vision over institutional safeguards. ## Regulatory and Legal Challenges ### Medical Device Regulation **FDA Oversight**: Neuralink operates under FDA jurisdiction as an investigational medical device. However: - FDA approval is based on safety and efficacy for intended use (treating paralysis) - Enhancement applications would require separate regulatory pathways - Long-term safety data won't exist for years or decades - Current regulations may be inadequate for brain-computer interfaces **International Regulatory Divergence**: Different countries have different standards for neural devices, potentially creating regulatory arbitrage where companies seek most permissive jurisdictions. ### Liability and Insurance **Unprecedented Liability Questions**: - Who is liable if a hacked implant causes harm? - What if the device malfunctions causing cognitive damage? - How are damages calculated for loss of cognitive function or personality changes? - Can liability waivers cover experimental brain surgery? **Insurance Industry**: Neural implants create new risk categories without actuarial data, making insurance markets uncertain. ### Human Rights and International Governance **Lack of International Framework**: No international treaties or agreements govern: - Neural data collection and use - Cross-border transfer of neural data - Rights of people with brain implants - Military use of neural technologies - Enhancement standards or limitations **Council of Europe and Other Bodies**: Some international organizations are beginning to address "neurorights" but binding agreements don't exist. **Implications**: This governance vacuum means rapid development may outpace ethical and legal frameworks, potentially creating harmful precedents difficult to reverse. ## Scientific and Medical Considerations ### Technical Challenges Not Fully Disclosed **Biocompatibility**: Long-term brain implants face challenges: - Foreign body response (glial scarring around electrodes) - Signal degradation over time - Infection risk - Need for device replacement/removal - Battery lifespan and replacement **Signal Interpretation**: Decoding neural signals is extraordinarily complex: - Significant individual variation in neural patterns - Need for extensive calibration and training - Adaptation as brain changes over time - Challenges scaling from simple cursor control to complex tasks **Bandwidth Limitations**: Despite claims of high electrode counts, current systems record from tiny fraction of brain's ~86 billion neurons. True "brain-computer symbiosis" would require orders of magnitude more sophisticated interfaces. ### Comparison to Alternative Approaches **Less Invasive Options**: - **Non-invasive BCIs**: EEG-based systems avoid surgery but have lower signal quality - **Endovascular approaches** (Synchron): Inserted through blood vessels, less brain damage - **Surface arrays** (Precision Neuroscience): Sit on brain surface without penetration **Trade-offs**: Neuralink's penetrating electrodes theoretically provide better signal quality but involve more risk and potential tissue damage. **Implications**: Medical ethics requires demonstrating that more invasive approaches are necessary and beneficial enough to justify risks. Neuralink must prove advantages over safer alternatives. ### Existing Capabilities in the Field **What Already Exists**: Academic research has already demonstrated: - Paralyzed patients controlling robotic arms with thought - Brain implants restoring communication for locked-in patients - Deep brain stimulation treating Parkinson's disease and depression - Cochlear implants restoring hearing **Neuralink's Actual Innovation**: Much of what Neuralink demonstrates (cursor control, communication) has precedent. Key potential innovations are: - Engineering refinement (wireless, cosmetic) - Electrode count and flexibility - Surgical robot automation - Integration and user interface **Implications**: While engineering advances are valuable, Musk's marketing often presents Neuralink as more revolutionary than the field's current state justifies. This can mislead public understanding and policy-makers about realistic timelines and capabilities. ## Financial Structure and Funding **Private Company**: Neuralink remains privately held with limited financial disclosure. **Known Funding**: - Elon Musk has provided substantial personal funding - 2021 funding round: $205 million (Series C) - 2023 funding round: Reportedly pursuing $1+ billion at approximately $5 billion valuation - Various earlier rounds totaling hundreds of millions **Investors**: Include venture capital firms and high-net-worth individuals, though complete investor list isn't public. **Revenue**: Neuralink currently generates no revenue. The path to profitability is uncertain: - Medical device market limited to patients with specific conditions - Reimbursement rates for novel procedures unclear - Enhancement market is speculative and faces regulatory uncertainty **Dependency on Musk**: The company appears dependent on Musk's continued financial support and public profile. His involvement in multiple demanding companies (Tesla, SpaceX, X/Twitter, xAI, Boring Company, Neuralink) raises questions about focus and sustainability. ## Geopolitical and Strategic Significance ### Technology Competition **US-China Dimension**: Neural technology represents a strategic technology domain: - China has substantial brain-computer interface research programs - US concerns about dependency on foreign neural technology for military or medical applications - Potential for neural surveillance and social control (particularly concerning given China's surveillance infrastructure) - Brain-computer interfaces could be seen as "commanding heights" technology **Defense Interest**: Pentagon's interest in neural interfaces for: - Enhancing soldier performance - Faster human-machine teaming - Treating traumatic brain injury - Creating "cyborg soldiers" **Implications**: Neuralink's development occurs within broader great power technology competition. The company's success or failure affects US technological leadership in a strategically significant domain. ### Societal Transformation Potential If successful, brain-computer interfaces could fundamentally alter human society: **Labor Markets**: - Cognitive enhancement could shift which skills are valuable - People without implants might be unemployable in certain fields - New forms of inequality based on neural capability **Social Relationships**: - Direct brain-to-brain communication could transform human interaction - Privacy boundaries would fundamentally change - New forms of intimacy or violation possible **Governance**: - How do we regulate thought itself if thoughts can be read? - Can neural data be subpoenaed in criminal cases? - What are rights of enhanced vs. non-enhanced people? **Human Nature**: The technology raises questions about consciousness, free will, personal identity, and what it means to be human. ## Current Status and Future Trajectory ### Near-Term (2025-2027) **Expected Developments**: - Continued small-scale human trials with paralysis patients - Refinement of technology based on initial patient experiences - Potential expansion of trial size if safety demonstrated - Possible attempts to demonstrate additional capabilities (e.g., controlling prosthetic limbs) - Continued competition from rival companies with potentially safer approaches **Challenges**: - Proving durability and long-term safety - Achieving FDA approval for commercial use (years away) - Demonstrating advantages over alternative approaches - Managing public expectations vs. technical reality - Addressing animal welfare and transparency concerns ### Medium-Term (2027-2035) **Potential Scenarios**: **Success Path**: - FDA approval for paralysis treatment - Expansion to other neurological conditions (blindness, deafness, seizures) - Demonstrated superiority over alternatives - Gradual safety record building trust - Possible early enhancement applications in controlled settings **Failure Path**: - Long-term complications emerging in patients - Competitor technologies proving superior - Regulatory obstacles preventing commercialization - Public backlash over privacy/safety concerns - Musk's attention diverted to other ventures **Most Likely**: Partial success with medical applications for specific conditions, enhancement applications remaining distant or limited to narrow uses. ### Long-Term (2035+) **Highly Speculative**: Musk's grand vision of AI-human symbiosis, memory upload/download, telepathy, and radical enhancement remains scientifically uncertain. Fundamental neuroscience questions about consciousness, memory encoding, and cognitive architecture aren't solved. Timeline for such capabilities, if physically possible at all, likely extends many decades beyond Musk's public predictions. ## Critical Analysis and Implications ### The Musk Factor Neuralink cannot be understood separately from Elon Musk's broader role in technology and culture: **Advantages**: - Musk's profile attracts talent, funding, and attention - His willingness to pursue extremely ambitious goals - Resources to fund development through inevitable setbacks - Track record of achieving difficult engineering goals (SpaceX reusability, Tesla scaling) **Disadvantages**: - Pattern of overpromising on timelines across all companies - Tendency to prioritize publicity over scientific process - Workplace cultures that may compromise careful development - Spreading attention across too many companies - Controversies that may affect regulatory relationships **Implications**: Neuralink's trajectory reflects tension between visionary ambition and scientific/regulatory reality. Musk's approach has worked for some challenges (rocket reusability) but human neurology may be less amenable to aggressive engineering timelines. ### Ethical Crossroads Neuralink represents a crossroads for humanity: **Optimistic View**: Brain-computer interfaces could: - Restore abilities to millions with paralysis, blindness, or neurological conditions - Reduce suffering from depression, PTSD, addiction - Expand human cognitive capabilities - Enable new forms of communication and connection - Help humanity remain relevant as AI advances **Pessimistic View**: The technology could: - Create unprecedented surveillance and control capabilities - Exacerbate inequality between enhanced and non-enhanced - Enable corporate or government manipulation of thought and behavior - Cause unforeseen psychological and neurological harms - Fundamentally compromise human autonomy and dignity **Reality**: Likely involves elements of both, making governance and ethical frameworks crucial now, before technology develops further. ### The Question of Governance Current regulatory frameworks are inadequate for neural technology: **What's Needed**: - International agreements on neural data rights - Standards for neural device security - Frameworks distinguishing medical use from enhancement - Liability structures for novel harms - Democratic input on whether/how to deploy enhancement technology - Protection against coerced adoption **Challenges**: - Technology developing faster than governance - International coordination difficult - Economic incentives favoring rapid deployment - Complexity making democratic deliberation challenging - Precedents being set by private companies before public debate **Implications**: The next decade will likely determine whether neural technology develops with adequate safeguards or whether ethical and rights frameworks are retrofitted after potentially harmful precedents are established. ## Conclusion Neuralink represents one of the most ambitious and consequential technology ventures of the 21st century. The company is attempting to create a direct interface between human brains and computers, with implications ranging from treating devastating disabilities to potentially transforming human nature itself. **Current Reality vs. Vision**: A significant gap exists between Musk's public messaging (imminent radical enhancement, AI symbiosis, telepathy) and demonstrated capabilities (early-stage medical device helping paralyzed individuals control cursors). This gap creates both excitement and concern about whether realistic assessment or hype drives development. **Key Uncertainties**: 1. **Technical**: Can the approach prove safe and effective long-term? Will it demonstrate advantages over competitors? 2. **Regulatory**: Will FDA and international regulators permit broader deployment? How will enhancement applications be governed? 3. **Ethical**: Will society develop adequate frameworks before deployment creates irreversible precedents? 4. **Commercial**: Can Neuralink become financially sustainable? Will markets for neural enhancement develop? 5. **Societal**: If successful, how will brain-computer interfaces transform human society, inequality, and what it means to be human? **Strategic Significance**: Neuralink's development occurs within broader contexts: - US-China technology competition - Race to develop and control strategic technologies - Acceleration of AI requiring human response - Increasing corporate power over fundamental aspects of human existence - Questions about democratic governance of transformative technologies The company's trajectory—shaped by Musk's vision, scientific reality, regulatory constraints, and public acceptance—will significantly influence whether neural technology develops as a medical breakthrough that reduces suffering or as a transformative and potentially destabilizing force reshaping human society without adequate democratic input or safeguards. Unlike social media platforms (which can be deleted) or even AI systems (which can be turned off), brain implants create permanent interventions in human neurology with potentially irreversible consequences. This makes getting development, governance, and deployment right not merely important but potentially civilizationally crucial.